Johnson & Johnson Acquires Egea Biosciences
Protein Therapeutics Pioneer to Complement Centocor R&D
21-May-2004 -
Centocor, Inc. announced that its parent company, Johnson & Johnson has acquired Egea Biosciences, Inc. of San Diego. Financial terms were not disclosed.
The acquisition of Egea, the pioneers of a technology platform designed to optimize protein therapeutics, will strengthen Centocor's position ...
antibodies
Bio-Medical Research
biologics
+6